|
1）Ema H, Suda T. Two anatomically distinct niches regulate stem cell activity. Blood. 2012; 120: 2174-81
|
|
|
|
2）Boulais PE, Frenette PS. Making sense of hematopoietic stem cell niches. Blood. 2015; 125: 2621-9
|
|
|
|
|
|
3）Bruns I, Lucas D, Pinho S, et al. Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion. Nat Med. 2014; 20: 1315-20
|
|
|
|
|
|
4）Zhao M, Perry JM, Marshall H, et al. Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells. Nat Med. 2014; 20: 1321-6
|
|
|
|
|
|
5）Nakamura-Ishizu A, Takubo K, Fujioka M, et al. Megakaryocytes are essential for HSC quiescence through the production of thrombopoietin. Biochem Biophys Res Commun. 2014; 454: 353-7
|
|
|
|
|
|
6）Chang Y, Bluteau D, Debili N, et al. From hematopoietic stem cells to platelets. J Thromb Haemost. 2007; 5: 318-27
|
|
|
|
|
|
7）Geddis AE. Megakaryopoiesis. Semin Hematol. 2010; 47: 212-9
|
|
|
|
|
|
8）Pallotta I, Lovett M, Kaplan DL, et al. Three-dimensional system for the in vitro study of megakaryocytes and functional platelet production using silk-based vascular tubes. Tissue Eng Part C Methods. 2011; 17: 1223-32
|
|
|
|
|
|
9）Kowalska MA, Rauova L, Poncz M. Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis. Thromb Res. 2010; 125: 292-6
|
|
|
|
|
|
10）Kasper B, Petersen F. Molecular pathways of platelet factor 4/CXCL4 signaling. Eur J Cell Biol. 2011; 90: 521-6
|
|
|
|
|
|
11）Yu M, Cantor AB. Megakaryopoiesis and thrombopoiesis: an update on cytokines and lineage surface markers. Methods Mol Biol. 2012; 788: 291-303
|
|
|
|
|
|
12）Zhao L, Hantash BM. TGF-β1 regulates differentiation of bone marrow mesenchymal stem cells. Vitam Horm. 2011; 87: 127-41
|
|
|
|
|
|
13）Samarakoon R, Overstreet JM, Higgins PJ. TGF-β signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities. Cell Signal. 2013; 25: 264-8
|
|
|
|
|
|
14）Poniatowski ŁA, Wojdasiewicz P, Gasik R, et al. Transforming growth factor beta family: insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications. Mediators Inflamm. 2015; 2015: 137823
|
|
|
|
|
|
15）Bartley TD, Bogenberger J, Hunt P, et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell. 1994; 77: 1117-24
|
|
|
|
|
|
16）Kaushansky K, Lok S, Holly RD, et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 1994; 369: 568-71
|
|
|
|
|
|
17）Kuter DJ, Beeler DL, Rosenberg RD. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci U S A. 1994; 91: 11104-8
|
|
|
|
|
|
18）Kato T, Ogami K, Shimada Y, et al. Purification and characterization of thrombopoietin. J Biochem. 1995; 118: 229-36
|
|
|
|